Agile 3+and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver disease

被引：12

作者：

Miura, Kouichi ^{[1
]}

Hayashi, Hideki ^{[2
]}

Kamada, Yoshihiro ^{[3
]}

Fujii, Hideki ^{[4
]}

Takahashi, Hirokazu ^{[5
]}

Oeda, Satoshi ^{[5
]}

Iwaki, Michihiro ^{[6
]}

Kawaguchi, Takumi ^{[7
]}

Tomita, Eiichi

Yoneda, Masato ^{[6
]}

Tokushige, Akihiro ^{[8
]}

Ueda, Shinichiro ^{[8
]}

Aishima, Shinichi ^{[9
]}

Sumida, Yoshio ^{[10
]}

Nakajima, Atsushi ^{[6
]}

Okanoue, Takeshi ^{[11
]}

机构：

[1] Jichi Med Univ, Dept Med, Div Gastroenterol, Shimotsuke, Japan

[2] Gifu Municipal Hosp, Dept Gastroenterol & Hepatol, Gifu, Japan

[3] Osaka Univ, Dept Adv Metab Hepatol, Grad Sch Med, Suita, Japan

[4] Osaka Metropolitan Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan

[5] Saga Univ Hosp, Liver Ctr, Saga, Japan

[6] Yokohama City Univ, Dept Gastroenterol & Hepatol, Grad Sch Med, Yokohama, Japan

[7] Kurume Univ, Dept Med, Div Gastroenterol, Sch Med, Kurume, Japan

[8] Univ Ryukyus, Dept Clin Pharmacol & Therapeut, Sch Med, Okinawa, Japan

[9] Saga Univ, Fac Med, Dept Pathol & Microbiol, Saga, Japan

[10] Int Univ Healthcare & Welf, Grad Sch Healthcare & Welf Management, Tokyo, Japan

[11] Saiseikai Suita Hosp, Dept Gastroenterol, Suita, Japan

来源：

HEPATOLOGY RESEARCH | 2023年 / 53卷 / 10期

基金：

日本学术振兴会;

关键词：

Agile score; comorbidity; fibrosis; NAFLD; noninvasive test; SCORING SYSTEM; RISK;

D O I：

10.1111/hepr.13938

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

AimThe noninvasive tests (NITs) Agile 3+ and Agile 4 effectively identify patients with nonalcoholic fatty liver disease (NAFLD) complicated with advanced fibrosis (F3-4) and cirrhosis (F4), respectively. Little information is available on associations between Agile scores and intra-/extrahepatic events. The aim of this study was to determine the predictive performance of Agile scores for intra-/extrahepatic events in Asian patients with biopsy-proven NAFLD. MethodsWe undertook a retrospective multicenter cohort study to investigate associations between intra-/extrahepatic events and two Agile scores, Agile 3+ and Agile 4. The scores were obtained by combining clinical parameters and liver stiffness measurement using transient elastography. ResultsAmong 403 enrolled patients, 11 had liver-related events (LREs), including seven with hepatocellular carcinoma (HCC). The incidence of LREs and HCC showed a stepwise increase in the advanced fibrosis group (F3-4), Agile 3+ rule-in (F3-4, highly suspected), and Agile 4 rule-in (F4, highly suspected) groups, compared to their counterparts. Hazard ratios for LREs in the advanced fibrosis group, Agile 3+ rule-in, and Agile 4 rule-in groups were 4.05 (p = 0.03), 23.5 (p = 0.003), and 45.5 (p < 0.001), respectively. The predictive performance results for Agile 3+ and Agile 4 were 0.780 and 0.866, respectively, which were higher than for fibrosis (0.595). Unlike for LREs, Agile scores failed to identify patients with extrahepatic events, including cardiovascular events and extrahepatic cancer. ConclusionsAgile 3+ and Agile 4 scores are excellent NITs for predicting LREs in patients with NAFLD, possibly without histological assessment.

引用

页码：978 / 988

页数：11

共 27 条

[1] Non-alcoholic Fatty Liver Disease: East Versus West [J].

Agrawal, Swastik ;

Duseja, Ajay K. .

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2012, 2 (02) :122-134

[2] Utility and Appropriateness of the Fatty Liver Inhibition of Progression (FLIP) Algorithm and Steatosis, Activity, and Fibrosis (SAF) Score in the Evaluation of Biopsies of Nonalcoholic Fatty Liver Disease [J].

Bedossa, Pierre .

HEPATOLOGY, 2014, 60 (02) :565-575

[3]

Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x

[4] Prevalence of NAFLD, MAFLD and associated advanced fibrosis in the contemporary United States population [J].

Ciardullo, Stefano ;

Perseghin, Gianluca .

LIVER INTERNATIONAL, 2021, 41 (06) :1290-1293

[5] Non-invasive diagnosis of non-alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature review [J].

Eguchi, Yuichiro ;

Wong, Gabriel ;

Akhtar, Omar ;

Sumida, Yoshio .

HEPATOLOGY RESEARCH, 2020, 50 (06) :645-655

[6] Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study [J].

Fujii, Hideki ;

Iwaki, Michihiro ;

Hayashi, Hideki ;

Toyoda, Hidenori ;

Oeda, Satoshi ;

Hyogo, Hideyuki ;

Kawanaka, Miwa ;

Morishita, Asahiro ;

Munekage, Kensuke ;

Kawata, Kazuhito ;

Yamamura, Sakura ;

Sawada, Koji ;

Maeshiro, Tatsuji ;

Tobita, Hiroshi ;

Yoshida, Yuichi ;

Naito, Masafumi ;

Araki, Asuka ;

Arakaki, Shingo ;

Kawaguchi, Takumi ;

Noritake, Hidenao ;

Ono, Masafumi ;

Masaki, Tsutomu ;

Yasuda, Satoshi ;

Tomita, Eiichi ;

Yoneda, Masato ;

Kawada, Norifumi ;

Tokushige, Akihiro ;

Kamada, Yoshihiro ;

Takahashi, Hirokazu ;

Ueda, Shinichiro ;

Aishima, Shinichi ;

Sumida, Yoshio ;

Nakajima, Atsushi ;

Okanoue, Takeshi .

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (02) :370-379

[7] Prediction of Liver-Related Events With a Combination of Liver Stiffness Measurements and Controlled Attenuation Parameters in Japanese Patients With Biopsy-Proven Non-alcoholic Fatty Liver Disease [J].

Hayashi, Hideki ;

Kamada, Yoshihiro ;

Fujii, Hideki ;

Takahashi, Hirokazu ;

Oeda, Satoshi ;

Iwaki, Michihiro ;

Kawaguchi, Takumi ;

Tomita, Eiichi ;

Yoneda, Masato ;

Tokushige, Akihiro ;

Ueda, Shinichiro ;

Aishima, Shinichi ;

Sumida, Yoshio ;

Nakajima, Atsushi ;

Okanoue, Takeshi .

ULTRASOUND IN MEDICINE AND BIOLOGY, 2023, 49 (07) :1658-1664

[8] Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 Diabetes [J].

Ishiba, Hiroshi ;

Sumida, Yoshio ;

Seko, Yuya ;

Tanaka, Saiyu ;

Yoneda, Masato ;

Hyogo, Hideyuki ;

Ono, Masafumi ;

Fujii, Hideki ;

Eguchi, Yuichiro ;

Suzuki, Yasuaki ;

Yoneda, Masashi ;

Takahashi, Hirokazu ;

Nakahara, Takashi ;

Mori, Kojiro ;

Kanemasa, Kazuyuki ;

Shimada, Keiji ;

Imajo, Kento ;

Yamaguchi, Kanji ;

Kawaguchi, Takumi ;

Nakajima, Atsushi ;

Chayama, Kazuaki ;

Shima, Toshihide ;

Fujimoto, Kazuma ;

Okanoue, Takeshi ;

Itoh, Yoshito .

HEPATOLOGY COMMUNICATIONS, 2021, 5 (04) :559-572

[9]

Ishiba H, 2018, J GASTROENTEROL, V53, P1216, DOI 10.1007/s00535-018-1474-y

[10] SWOT analysis of noninvasive tests for diagnosing NAFLD with severe fibrosis: an expert review by the JANIT Forum [J].

Kamada, Yoshihiro ;

Nakamura, Takahiro ;

Isobe, Satoko ;

Hosono, Kumiko ;

Suama, Yukiko ;

Ohtakaki, Yukie ;

Nauchi, Arihito ;

Yasuda, Naoto ;

Mitsuta, Soh ;

Miura, Kouichi ;

Yamamoto, Takuma ;

Hosono, Tatsunori ;

Yoshida, Akihiro ;

Kawanishi, Ippei ;

Fukushima, Hideaki ;

Kinoshita, Masao ;

Umeda, Atsushi ;

Kinoshita, Yuichi ;

Fukami, Kana ;

Miyawaki, Toshio ;

Fujii, Hideki ;

Yoshida, Yuichi ;

Kawanaka, Miwa ;

Hyogo, Hideyuki ;

Morishita, Asahiro ;

Hayashi, Hideki ;

Tobita, Hiroshi ;

Tomita, Kengo ;

Ikegami, Tadashi ;

Takahashi, Hirokazu ;

Yoneda, Masato ;

Jun, Dae Won ;

Sumida, Yoshio ;

Okanoue, Takeshi ;

Nakajima, Atsushi ;

JANIT Forum .

JOURNAL OF GASTROENTEROLOGY, 2023, 58 (02) :79-97

← 1 2 3 →